EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ScRNA‐Seq Reveals Jiangfu Zhixie Formula Alleviates IBS‐D by Inhibiting Macrophage M1 Polarization through HIF‐1α‐Glycolysis Axis

Xiaosong Xu iD, Yao Du iD, Lipeng Du, Wanning Zhang, Bowen Guo, Yanru Cai, Tianyi Zhang

Immunity, Inflammation and Disease · 2026-11 · 14 (11)

DOI: 10.1002/iid3.70599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 05.11.2026. Verfasst von Xiaosong Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Center, Hebei Provincial Hospital of Chinese Medicine, Hebei, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Macrophages, Drugs, Chinese Herbal, Irritable Bowel Syndrome. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province, Hebei Institute of Traditional Chinese Medicine Pharmaceutical Preparation Industry Technology, Hebei Provincial Government Funding Clinical Medicine Excellent Talents Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Irritable bowel syndrome with diarrhea (IBS‐D) remains a challenging condition to manage due to its chronic nature and the limited long‐term efficacy of current treatments. The traditional Chinese herbal formula Jiangfu Zhixie (JFZX) has shown clinical benefits, but its underlying mechanisms remain unclear.

Aim

This study aimed to investigate the therapeutic effects of JFZX on IBS‐D and elucidate its molecular mechanisms, focusing on macrophage polarization and the HIF‐1α‐glycolysis axis.

Methods

An IBS‐D mouse model was established by senna leaf infusion combined with restraint stress. Mice were treated with varying doses of JFZX or pinaverium bromide (positive control) for 14 days. Diarrhea symptoms, visceral hypersensitivity, and intestinal barrier integrity were assessed. Single‐cell RNA sequencing (scRNA‐seq) was performed on colon tissues to analyze cellular composition and intercellular interactions. In vitro, LPS‐stimulated RAW264.7 macrophages were treated with JFZX‐medicated serum to evaluate M1 polarization, cytokine secretion (IL‐1β, TNF‐α), and expression of HIF‐1α and glycolysis‐related proteins (GLUT1, LDHA).

Results

JFZX treatment significantly ameliorated diarrhea, reduced visceral hypersensitivity, and restored intestinal barrier integrity in IBS‐D mice, accompanied by upregulation of tight junction proteins ZO‐1 and Occludin. scRNA‐seq revealed that JFZX reshaped the colonic cellular landscape, attenuating myeloid‐epithelial interactions and reducing the proportion of pro‐inflammatory M1‐like macrophages. Mechanistically, HIF‐1α was identified as a key driver of M1 polarization in IBS‐D. JFZX suppressed HIF‐1α expression and its downstream glycolytic pathway (GLUT1, LDHA) both in vivo and in vitro, thereby inhibiting M1 macrophage polarization and decreasing IL‐1β and TNF‐α secretion in LPS‐stimulated macrophages.

Conclusion

JFZX alleviates IBS‐D by inhibiting M1 macrophage polarization through suppression of the HIF‐1α‐glycolysis axis, highlighting its potential as a therapeutic agent for IBS‐D and identifying HIF‐1α as a promising target for intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitMacrophagesDrugs, Chinese HerbalIrritable Bowel SyndromeGlycolysisDiarrheaAnimalsMiceMaleMacrophage ActivationRAW 264.7 CellsRNA-SeqDisease Models, Animal

Stichwörter der Autor:innen

HIF‐1 αJiangfu Zhixie formulaglycolysisirritable bowel syndrome with diarrheamacrophage polarizationsingle‐cell rna sequencing

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitDrugs, Chinese HerbalHif1a protein, mouse

Autor:innen und Institutionen

  • Research Center, Hebei Provincial Hospital of Chinese Medicine, Hebei, China.
  • Department of Spleen and Stomach Diseases, Hebei Provincial Hospital of Chinese Medicine, Hebei, China.

ORCID-Profile: Xiaosong Xu, Yao Du

Förderung

  • Natural Science Foundation of Hebei Province
  • Hebei Institute of Traditional Chinese Medicine Pharmaceutical Preparation Industry Technology
  • Hebei Provincial Government Funding Clinical Medicine Excellent Talents Project
  • Research Plan Project of Hebei Provincial Administration of Traditional Chinese Medicine
  • Medical Science Research Project of Hebei

Zitieren

APA

Xu, X., Du, Y., Du, L., Zhang, W., Guo, B., Cai, Y., & Zhang, T. (2026). ScRNA‐Seq Reveals Jiangfu Zhixie Formula Alleviates IBS‐D by Inhibiting Macrophage M1 Polarization through HIF‐1α‐Glycolysis Axis. Immunity, Inflammation and Disease, 14(11). https://doi.org/10.1002/iid3.70599

Vancouver

Xu X, Du Y, Du L, Zhang W, Guo B, Cai Y, et al. ScRNA‐Seq Reveals Jiangfu Zhixie Formula Alleviates IBS‐D by Inhibiting Macrophage M1 Polarization through HIF‐1α‐Glycolysis Axis. Immunity, Inflammation and Disease. 2026;14(11). doi:10.1002/iid3.70599

BibTeX
@article{Xu2026,
  author = {Xu, Xiaosong and Du, Yao and Du, Lipeng and Zhang, Wanning and Guo, Bowen and Cai, Yanru and Zhang, Tianyi},
  title = {ScRNA‐Seq Reveals Jiangfu Zhixie Formula Alleviates IBS‐D by Inhibiting Macrophage M1 Polarization through HIF‐1α‐Glycolysis Axis},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {11},
  doi = {10.1002/iid3.70599}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche